Cargando…

TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects

Detalles Bibliográficos
Autor principal:	Lu, Hailing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939428/ https://www.ncbi.nlm.nih.gov/pubmed/24624132 http://dx.doi.org/10.3389/fimmu.2014.00083

Ejemplares similares

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
por: Chester, Cariad, et al.
Publicado: (2015)

Co-stimulatory agonists: An insight into the immunotherapy of cancer
por: Pourakbari, Ramin, et al.
Publicado: (2021)

T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
por: Zheng, Chunjiao, et al.
Publicado: (2023)

Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases
por: He, Weiwei, et al.
Publicado: (2019)

The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
por: Kumar, Sandeep, et al.
Publicado: (2018)

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
por: Rapoport, Bernardo L., et al.
Publicado: (2022)

T Cell-Mediated Modulation of Mast Cell Function: Heterotypic Adhesion-Induced Stimulatory or Inhibitory Effects
por: Mekori, Yoseph A., et al.
Publicado: (2012)

Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma
por: Hajiabadi, Sare, et al.
Publicado: (2023)

Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives
por: Dadas, Osman, et al.
Publicado: (2023)

TLR4-mediated release of heparin-binding protein in human airways: a co-stimulatory role for IL-26
por: Paulsson, Magnus, et al.
Publicado: (2023)

T Cell Extracellular Traps: Tipping the Balance Between Skin Health and Disease
por: Ouyang, Kelsey, et al.
Publicado: (2022)

TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease
por: Mifsud, Edin J., et al.
Publicado: (2014)

TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
por: Owen, Allison M., et al.
Publicado: (2021)

TLR9 Activation Is Triggered by the Excess of Stimulatory versus Inhibitory Motifs Present in Trypanosomatidae DNA
por: Khan, Mélissa Erin, et al.
Publicado: (2014)

The Curious Case of Type I IFN and MxA: Tipping the Immune Balance in AIDS
por: Furuya, Andrea Kinga Marias, et al.
Publicado: (2014)

Modulation of urelumab glycosylation separates immune stimulatory activity from organ toxicity
por: Reitinger, Carmen, et al.
Publicado: (2022)

Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine
por: Zhou, Shi-Hao, et al.
Publicado: (2022)

Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells
por: Møller, Sofie H., et al.
Publicado: (2020)

Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?
por: Ville, Simon, et al.
Publicado: (2015)

A novel defined TLR3 agonist as an effective vaccine adjuvant
por: Ko, Kwang Hyun, et al.
Publicado: (2023)

Competition between concanavalin A-induced stimulatory and inhibitory effects in the in vitro immune response to antigen
Publicado: (1975)

Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction
por: Mostböck, Sven, et al.
Publicado: (2022)

New players tip the scales in the balance between excitatory and inhibitory synapses
por: Levinson, Joshua N, et al.
Publicado: (2005)

Differential Response of Gestational Tissues to TLR3 Viral Priming Prior to Exposure to Bacterial TLR2 and TLR2/6 Agonists
por: Rasheed, Zahirrah B. M., et al.
Publicado: (2020)

Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors
por: Frey, Benjamin, et al.
Publicado: (2017)

Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
por: Salomon, Ran, et al.
Publicado: (2022)

Development of a novel TLR8 agonist for cancer immunotherapy
por: Wang, Yuxun, et al.
Publicado: (2020)

Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
por: Jeong, Seongju, et al.
Publicado: (2020)

Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2021)

Chronic Exposure of Gingival Fibroblasts to TLR2 or TLR4 Agonist Inhibits Osteoclastogenesis but Does Not Affect Osteogenesis
por: Karlis, Gerasimos D., et al.
Publicado: (2020)

DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects
por: Ota, Yosuke, et al.
Publicado: (2023)

Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy
por: Wei, Huafeng, et al.
Publicado: (2014)

Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation
por: Auderset, Floriane, et al.
Publicado: (2019)

Immunotherapies targeting stimulatory pathways and beyond
por: Marin-Acevedo, Julian A., et al.
Publicado: (2021)

INHIBITORY AND STIMULATORY EFFECTS OF CONCANAVALIN A ON THE RESPONSE OF MOUSE SPLEEN CELL SUSPENSIONS TO ANTIGEN : II. EVIDENCE FOR SEPARATE STIMULATORY AND INHIBITORY CELLS
por: Dutton, Richard W.
Publicado: (1973)

Investigation of the association between the genetic polymorphisms of the co-stimulatory system and systemic lupus erythematosus
por: Chen, Ding-Ping, et al.
Publicado: (2022)

Exploration of the association between the single-nucleotide polymorphism of co-stimulatory system and rheumatoid arthritis
por: Chen, Ding-Ping, et al.
Publicado: (2023)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023)

Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations
por: Reckamp, Karen L, et al.
Publicado: (2020)

Correction to: Development of a novel TLR8 agonist for cancer immunotherapy
por: Wang, Yuxun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ccpd0cpcj7cjpf1p6nfn2sumrg